secwatch.observer — SEC 8-K summary
======================================

Issuer:     PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
CIK:        0001299130
Form:       8-K
Filed at:   2026-02-02T23:59:59+00:00
Accession:  0001104659-26-009014
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PacBio completes sale of short-read sequencing assets to Illumina for $48.1M net cash
--------------------------------------------------------------------------------

- Sold certain short-read DNA sequencing IP and related technologies to Illumina for $50M gross; net cash proceeds $48.1M.
- Illumina assumed certain liabilities and granted PacBio a non-exclusive license back to certain IP.
- Transaction closed Jan 30, 2026; company to focus on long-read sequencing and accelerate SPRQ-Nx chemistry launch.
- Proceeds strengthen balance sheet; $1.9M paid to former Apton equity holders to waive milestone obligations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1299130/000110465926009014/0001104659-26-009014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1299130/000110465926009014/tm264755d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-009014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer